Skip to main navigation Skip to search Skip to main content

Erratum: VBP15: Preclinical characterization of a novel anti-inflammatory delta 9,11 steroid (Bioorganic and Medicinal Chemistry (2013) 21 (2241-2249) DOI: 10.1016/j.bmc.2015.01.034)

  • ReveraGen BioPharma, Inc.
  • LLC

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish
Pages (from-to)1664
Number of pages1
JournalBioorganic and Medicinal Chemistry
Volume23
Issue number7
DOIs
StatePublished - Apr 1 2015

Fingerprint

Dive into the research topics of 'Erratum: VBP15: Preclinical characterization of a novel anti-inflammatory delta 9,11 steroid (Bioorganic and Medicinal Chemistry (2013) 21 (2241-2249) DOI: 10.1016/j.bmc.2015.01.034)'. Together they form a unique fingerprint.

Cite this